FDA Inspection 946302 — UCB Pharma S.A.
The FDA completed an inspection of UCB Pharma S.A. on Sep 11, 2015 in Braine-L'Alleud. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 11, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Braine-L'Alleud (Belgium)